Clinical profile of patients with renal stone disease in a tertiary care hospital in Navi Mumbai

Autor: Rohith Pillai, Raj Gautam, Aniket Ray, Pranav Narayan, Anuradha Panchal, Mukul Mapari

Publikováno v: International Journal of Surgery Science. 4:288-291

Renal stones is a common condition affecting human beings of both genders and all age groups worldwide. Their presentation vary from unilateral loin region pain to nausea vomiting, to burning micturation or even haematuria. Patient profile of renal s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2550a81d472b4dfa06d48f1f69510b59
https://doi.org/10.33545/surgery.2020.v4.i3e.510

Excision of intra-abdominal mesenteric immature teratoma during COVID-19 pandemic

Autor: Aniket Ray, Seema Barman, Jeena K. Sathyan, Shravani Shetye, Varsha Sharma, Manmohan Kamat

Publikováno v: International Surgery Journal. 7:4221

The world is suffering from the COVID-19 pandemic. Nature has thrown a new challenge towards the healthcare professionals in the form of this new virus. As if that was not enough, we found an extremely rare, interesting and challenging case of mesent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::331c8cff5bead04ce1d998c2404ab6b9
https://doi.org/10.18203/2349-2902.isj20205387

Arsenic body- burden in coronary heart disease cases of West Bengal, India

Autor: De Auley, Haldar Ajanta, Podder Gargi, Adhikari Aniket, Ray Saumitra, Banerjee Jayshree, De Madhusnata

Publikováno v: International Journal of Medical Research and Health Sciences, Vol 2, Iss 1, Pp 8-18 (2013)

Background: Coronary Heart Disease is a big concern for the health of the residents of India. Environmental contaminants, air pollutants, synthetic chemicals, and the mineral content in drinking water can affect the heart by altering the heart rate,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::5d67457f43828eadc84c97cb4383cb41
http://ijmrhs.com/wp-content/uploads/2013/01/2.pdf

Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial

Autor: Mirjam Stahl, Jobst Roehmel, Monika Eichinger, Felix Doellinger, Lutz Naehrlich, Matthias V Kopp, Anna-Maria Dittrich, Christopher Lee, Olaf Sommerburg, Simon Tian, Tu Xu, Pan Wu, Aniket Joshi, Partha Ray, Margaret E Duncan, Mark O Wielpütz, Marcus A Mall

Publikováno v: Stahl, Mirjam; Roehmel, Jobst; Eichinger, Monika; Doellinger, Felix; Naehrlich, Lutz; Kopp, Matthias V; Dittrich, Anna-Maria; Lee, Christopher; Sommerburg, Olaf; Tian, Simon; Xu, Tu; Wu, Pan; Joshi, Aniket; Ray, Partha; Duncan, Margaret E; Wielpütz, Mark O; Mall, Marcus A (2023). Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial. (In Press). Annals of the American Thoracic Society American Thoracic Society 10.1513/AnnalsATS.202208-684OC

RATIONALE Lumacaftor/ivacaftor (LUM/IVA) was shown to be safe and well tolerated in children 2 through 5 years of age with cystic fibrosis (CF) homozygous for F508del-CFTR in a phase 3 open-label study. Improvements in sweat chloride concentration, m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24e19cda186c75d3824ee95ea401bdc3

A comparative study of classification algorithms for risk prediction in pregnancy.

Autor: Lakshmi B.N., Indumathi T.S., Ravi, Nandini

Publikováno v: TENCON 2015 - 2015 IEEE Region 10 Conference; 2015, p1-6, 6p